Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger E G Schutgens

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Clinical Case Reports|September 23, 2021
Glanzmann thrombasthenia complicated by frequent myeloproliferative neoplasm-related thromboembolism: thrombosis occurring regardless of αIIbβIII integrin deficiencyRoger E G Schutgens, Rolf T Urbanus
Seminars in Thrombosis and Hemostasis|March 20, 2018
Toward Flow Cytometry Based Platelet Function DiagnosticsIvar van Asten, Roger E G Schutgens, Rolf T Urbanus
Hamostaseologie|December 15, 2016
Management of cardiovascular disease in aging persons with haemophiliaRoger E G Schutgens, Michiel Voskuil, Evelien P Mauser-Bunschoten
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2023
No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patientsSarah J Schep, Kathelijn Fischer, Marianne Boes, et al.
American Journal of Hematology|June 26, 2009
An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosisFred J L M Haas, Roger E G Schutgens, Douwe H Biesma
British Journal of Haematology|May 27, 2005
Reduced efficacy of clinical probability score and D-dimer assay in elderly subjects suspected of having deep vein thrombosisRoger E G Schutgens, Fred J L M Haas, Douwe H Biesma
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 15, 2014
Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in EuropeRoger E G Schutgens, R Klamroth, I Pabinger, et al.
Blood|October 20, 2009
How I treat age-related morbidities in elderly persons with hemophiliaPier M Mannucci, Roger E G Schutgens, Elena Santagostino, et al.
Hemasphere|April 26, 2021
Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia ASarah J Schep, Roger E G Schutgens, Kathelijn Fischer, et al.
American Journal of Hematology|October 24, 2012
Persistent A-antigen after stem cell transplantation of blood group A patient with non-A donorKaren M K de Vooght, Roger E G Schutgens, Wouter W van Solinge
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Clinical Case Reports|September 23, 2021
Glanzmann thrombasthenia complicated by frequent myeloproliferative neoplasm-related thromboembolism: thrombosis occurring regardless of αIIbβIII integrin deficiencyRoger E G Schutgens, Rolf T Urbanus
Seminars in Thrombosis and Hemostasis|March 20, 2018
Toward Flow Cytometry Based Platelet Function DiagnosticsIvar van Asten, Roger E G Schutgens, Rolf T Urbanus
Hamostaseologie|December 15, 2016
Management of cardiovascular disease in aging persons with haemophiliaRoger E G Schutgens, Michiel Voskuil, Evelien P Mauser-Bunschoten
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 5, 2023
No immunological changes after factor VIII product switch: An in depth analysis in haemophilia A patientsSarah J Schep, Kathelijn Fischer, Marianne Boes, et al.
American Journal of Hematology|June 26, 2009
An age-adapted approach for the use of D-dimers in the exclusion of deep venous thrombosisFred J L M Haas, Roger E G Schutgens, Douwe H Biesma
British Journal of Haematology|May 27, 2005
Reduced efficacy of clinical probability score and D-dimer assay in elderly subjects suspected of having deep vein thrombosisRoger E G Schutgens, Fred J L M Haas, Douwe H Biesma
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 15, 2014
Atrial fibrillation in patients with haemophilia: a cross-sectional evaluation in EuropeRoger E G Schutgens, R Klamroth, I Pabinger, et al.
Blood|October 20, 2009
How I treat age-related morbidities in elderly persons with hemophiliaPier M Mannucci, Roger E G Schutgens, Elena Santagostino, et al.
Hemasphere|April 26, 2021
Role of Regulatory Cells in Immune Tolerance Induction in Hemophilia ASarah J Schep, Roger E G Schutgens, Kathelijn Fischer, et al.
American Journal of Hematology|October 24, 2012
Persistent A-antigen after stem cell transplantation of blood group A patient with non-A donorKaren M K de Vooght, Roger E G Schutgens, Wouter W van Solinge
Pageof 16